Two novel ternary albendazole-cyclodextrin-polymer systems: Dissolution, bioavailability and efficacy against Taenia crassiceps cysts

Acta Tropica

Volumn 113, Issue 1, 2010, Pages 56-60

  Palomares Alonso, Francisca ^a,b   González, Cesar Rivas ^b   Bernad Bernad, Ma Josefa ^b   Montiel, María Dolores Castillo ^b   Hernández, Guadalupe Palencia ^a   González Hernández, Iliana ^a   Castro Torres, Nelly ^a   Estrada, Enrique Pinzón ^c   Jung Cook, Helgi ^a,b  

^a NATIONAL INSTITUTE OF NEUROLOGY AND NEUROSURGERY   (Mexico)

^b Universidad Nacional Autonoma de Mexico Facultad de Quimica   (Mexico)

^c UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Albendazole; Bioavailability; Taenia crassiceps cysts; Ternary systems

Indexed keywords

ALBENDAZOLE; BETA CYCLODEXTRIN; CYCLODEXTRIN; PECTIN; PLACEBO; POLYMER; POVIDONE;

BIOAVAILABILITY; CYST; DISEASE; DISSOLUTION; POLYMER;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG FORMULATION; DRUG SCREENING; DRUG SOLUBILITY; HELMINTHIASIS; MALE; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; RAT; SUSPENSION; TAENIA CRASSICEPS; TAENIASIS;

ALBENDAZOLE; ANIMALS; ANTICESTODAL AGENTS; BETA-CYCLODEXTRINS; MALE; MICE; MICE, INBRED BALB C; PECTINS; RATS; RATS, WISTAR; TAENIA;

TAENIA CRASSICEPS;

EID: 71549138754     PISSN: 0001706X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.actatropica.2009.09.006     Document Type: Article

References (28)

1. Ammar H.O., Salama H.A., Ghorab M., and Mahmoud A.A. Formulation and biological evaluation of glimepiride-cyclodextrin-polymer systems. Int. J. Pharm. 309 (2006) 129-138
2. Castillo J., Palomo-Canales J., García J., Bolas F., and Torrado J. Preparation and characterization of albendazol β-cyclodextrin complexes. Drug. Dev. Ind. Pharm. 25 (1999) 1241-1248
3. Casulli A., Gomez M.A., Gallinella B., Turchetto L., and Poizo E. 2-Hydroxypropyl-beta-cyclodextrin improves the effectiveness of albendazole against encapsulated larvae of Trichinella spiralis in a murine model. J. Antimicrob. Chemother. 58 (2006) 886-890
4. Daniel-Mwambete K., Torrado S., Cuesta-Bandera C., Ponce-Gordo F., and Torrado J.J. The effect of solubilization on the bioavailability of three benzimidazole carbamate drugs. Int. J. Pharm. 272 (2004) 29-36
5. Del Brutto O.H., Roos K.L., Coffey C.S., and García H.H. Meta-analysis: cysticidal drugs for neurocysticercosis: albendazole and praziquantel. Ann. Intern. Med. 145 (2006) 43-51
6. Evrard B., Chiap P., DeTullio P., Ghalmi F., Piel G., Van Hess T., Crommen J., Losson B., and Delattre L. Oral bioavailability in sheep of albendazole from a suspension and from a solution containing hydroxypropyl-β-cyclodextrin. J. Control. Release 85 (2002) 45-50
7. García-Rodríguez J., Torrado J., and Bolas F. Improving bioavailability and anthelmintic activity of albendazole by preparing albendazole-cyclodextrin complexes. Parasite 8 (2001) 188-190
8. Gottschall D.W., Theodorides V.J., and Wang R. The metabolism of benzimidazole anthelmintics. Parasitol. Today 6 (1990) 115-124
9. Itoh K., Hirayama T., Takahashi A., Kubo W., Miyazaki S., Dairaku M., Togashi M., Mikami R., and Attwood D. In situ gelling pectin formulations for oral drug delivery at high gastric pH. Int. J. Pharm. 20 (2007) 90-96
10. Jung H., Medina L., García L., Fuentes I., and Esparza R. Absorption studies of albendazole and some physicochemical properties of the drug and its metabolite, albendazole sulphoxide. J. Pharm. Pharmacol. 50 (1998) 43-48
11. Kalaiselvan R., Mohnata G.P., Manna P.K., and Manimekalai A. Solid-phase preparation and characterization of albendazole solid dispersion. ARS Pharm. 47 (2006) 91-107
12. Kalaiselvan R., Mohanta G.P., Manna P.K., and Manavalan R. Multicomponent system of albendazole with cyclodextrin and hydroxyacids. Acta Pharm. Sci. 48 (2006) 19-33
13. Kalaiselvan R., Mohanta G.P., Manna P.K., and Manavalan R. Inhibition of albendazole crystallization in polyvinylpyrrolidone solid molecular dispersions. Pharmazie 61 (2006) 618-624
14. Kalaiselvan R., Mohanta G.P., Madhusudan S., Manna P.K., and Manavalan R. Enhancement of bioavaliability and anthelmintic efficacy of albendazole by solid dispersion and cyclodextrin complexation techniques. Pharmazie 62 (2007) 604-607
15. Khalikov S.S., Kutlymuratov A.P., Kristallovich E.L., Abdullaev N.D., Knodzhaeva M.A., Sadykov T., and Aripov K. Modification on the solubility of benzimidazole drugs on mechanical treatment with pectins. Chem. Nat. Comp. 31 (1995) 460-464
16. Loftsson T., Fri{eth}riksdóttir H., Sigur{eth}adottir A.M., and Ueda H. The effect of water-soluble polymers on drug-cyclodextrin complexation. Int. J. Pharm. 110 (1994) 169-177
17. Loftsson T., and Fri{eth}riksdóttir H. The effect of water-soluble polymers on the aqueous solubility and complexing abilities of β-cyclodextrin. Int. J. Pharm. 163 (1998) 115-121
18. Palomares F., Palencia G., Perez R., Gonzalez-Esquivel D., Castro N., and Jung C.H. In vitro effects of albendazole sulphoxide and praziquantel against Taenia solium and Taenia crassiceps cysts. Antimicrob. Agents Chemother. 48 (2004) 1051-1054
19. Patel R.P., and Patel M.M. Physicochemical characterization and dissolution study of solid dispersion of lovastatin with polyethylene glycol 4000 and polyvinylpyrrolidone K30. Pharm. Dev. Technol. 12 (2007) 21-33
20. Rawden H.C., Kokwaro G.O., Ward S.A., and Edwards G. Relative contribution of cytochromes P450 and flavin-containing monoxigenases to the metabolism of albendazole by human liver microsomes. Br. J. Clin. Pharmacol. 49 (2000) 313-322
21. Redondo P.A., Álvarez A.I., Garcia J.L., Villaverde C., and Prieto J.G. Influence of surfactants on oral bioavailability of albendazole based on the formation of the sulphoxide metabolites in rats. Biopharm. Drug Dispos. 19 (1998) 65-70
22. Ribeiro L., Ferreira D., and Veiga F. Physicochemical investigation of the effect of water-soluble polymers on vinpocetine complexation with β-cyclodextrin and its sulfobutyl ether derivative in solution and solid state. Eur. J. Pharm. Sci. 20 (2003) 253-266
23. Rigter I.M., Schipper H.G., Koopmans R.P., Van Kan H.J.M., Frijlink H.W., Kager P.A., and Guchelaar H.J. Relative bioavailability of three newly developed albendazole formulations: a randomized crossover study with healthy volunteers. Antimicrob. Agents Chemother. 48 (2004) 1051-1054
24. Saha P., and Kou J.H. Effect of solubilizing excipients on the permeation of poorly water-soluble compounds across Caco-2 cell monolayers. Eur. J. Pharm. Biopharm. 50 (2000) 403-411
25. Soria-Arteche O., Castillo R., Hernandez-Campos A., Hurtado-de la Peña M., Navarrete-Vázquez G., Medina-Franco J.L., and Gómez-Flores K. Studies on the selective S-oxidation of albendazole, febendazole, triclabendazole, and other benzimidazole sulfides. J. Mex. Chem. Soc. 49 (2005) 353-358
26. Stella V.J., and He Q. Cyclodextrins. Toxicol. Pathol. 36 (2008) 30-42
27. Torrado S., Torrado S., Torrado J.J., and Cadórniga R. Preparation, dissolution and characterization of albendazole solid dispersions. Int. J. Pharm. 140 (1996) 247-250
28. Valero M., Pérez-Revuelta B.I., and Rodríguez L.J. Effect of PVP K-25 on the formation of the naproxen: β-cyclodextrin complex. Int. J. Pharm. 253 (2003) 97-110